(b)(4).This report is for a breach in aseptic technique which resulted in peritonitis.Per baxter labeling, users are instructed to use aseptic technique when performing peritoneal dialysis therapy.A review of the label for the product family will be conducted.Should additional relevant information become available, a supplemental report will be submitted.
|
It was reported that a patient experienced a breach in aseptic technique which resulted in peritonitis coincident with peritoneal dialysis therapy.There was no further description of the breach in aseptic technique.Peritonitis was manifested by abdominal pain.On the day of onset, the patient was hospitalized for the peritonitis event.Beginning on the day of onset, the patient was treated with unspecified antibiotics (route, medication, dosage, frequency, and duration not reported) for the peritonitis event.Antibiotic treatment was ongoing.The care plan was to treat the patient with intraperitoneal vancomycin (dosage, frequency, and duration not reported) upon hospital discharge for the peritonitis event.On an unreported date, dianeal therapies were discontinued and the patient was switched to hemodialysis therapy, but the care plan was to return the patient to peritoneal dialysis therapy upon discharge from the hospital.Hospitalization was ongoing.The patient was recovering from the peritonitis event.It was not reported if the patient was retrained on the proper aseptic technique.No additional information is available.
|